Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanda Pharmaceuticals
This is an open label study to investigate the efficacy and safety of tradipitant in motion sickness affected male and female participants during events historically known to cause motion sickness.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
History of Motion Sickness
Age 18-75
You may not be if
Nausea-inducing disorder other than motion sickness
BMI \> 40
History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists
